Nemaura Medical Inc (NASDAQ:NMRD) posted its earnings results on Tuesday. The company reported $0.00 earnings per share for the quarter, Zacks reports.

ILLEGAL ACTIVITY NOTICE: This article was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The correct version of this article can be read at

Nemaura Medical Company Profile

Nemaura Medical, Inc is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company’s focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source.

Receive News & Ratings for Nemaura Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemaura Medical Inc and related companies with's FREE daily email newsletter.